Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 242
Selected: 0
NCT IDTitle
NCT06500507A Study of QLS4131 in Patients With Recurrent or Refractory Multiple Myeloma
NCT07074236Pharmacokinetics and Pharmacodynamics Study
NCT06954246A Study of MHB088C Injection Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
NCT07489586A Clinical Study of QL1207H Injection Versus Aflibercept for Neovascular Age-related Macular Degeneration
NCT05052567CEND-1 Injection (QLC12102) in Patients With Advanced Metastatic Pancreatic Ductal Adenocarcinoma
NCT05488821Safety, Tolerability and Pharmacokinetics Study of QLH11906 in Patients With Advanced Solid Tumors Harboring MAPK Pathway Alterations.
NCT06614907A PhaseⅠ Comparative Study to Evaluate the Pharmacokinetics of QL2108 to Dupixent®
NCT06616571Compare the Efficacy and Safety of QL0605 Injections at Different Timepoints
NCT07138885A Phase II, Single-Arm, Prospective Trial on the Efficacy and Safety of QL1706 Combination Regimen as Second-Line Therapy for Targeted-Immunotherapy-Resistant Hepatocellular Carcinoma
NCT03750916Anlotinib Combined With Docetaxel for Advanced Non-squamous Non-Small Cell Lung Cancer
NCT06864793Study on the Pharmacokinetics and Safety of QL1012D and Gonal-F® in Healthy Female Volunteers
NCT01946919Post-Marketing Surveillance of the Cinepazide Maleate Injection: a Real World Study
NCT07344051A Phase II Study of QLS12010 Capsules in Adults With Moderate to Severe Atopic Dermatitis
NCT07061639A Study of QLS5133 Monotherapy in Advanced Solid Tumors
NCT07667751An Exploratory Study on the Use of Ipalotinib (Tislelizumab) Combined With Sunitinib and Olaparib for Neoadjuvant Therapy in HRD-positive Advanced Ovarian Cancer
NCT06446388Study of QLS31905 and/or QL1706 Combination With Chemotherapy in the Advanced Malignant Solid Tumors
NCT07358858A Food Effect Study of QLS1410 in Healthy Chinese Adults
NCT05329025A Study of QL1706 Combined With Chemotherapy in Advanced Non-small Cell Lung Cancer
NCT07716449QLS31905 in Combination With CAPOX Versus Sintilimab in Combination With CAPOX as First-line Treatment in Patients With GC/GEJ
NCT06942767Combination of QLS31905, QL2107 and Chemotherapy as First-line Therapy in CLDN18.2-positive Unresectable Locally Advanced or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
NCT06925659A Study of QLM2011 in Subjects With Advanced Solid Tumors
NCT05823246Safety and Efficacy Study of QLF31907 in Advanced Melanoma and Urothelial Carcinoma
NCT04213105Comparing of the Pharmacokinetic, Safety and Pharmacodynamic of QL1206 and Prolia® in Healthy Adults
NCT07828873A Single-Arm Study of QL1706 Combined With DOS as Neoadjuvant Therapy for Locally Advanced Gastric/GEJ Adenocarcinoma
NCT06371534A Study Comparing Pharmacokinetic and Safety of QL2109 and DARZALEX FASPRO® in Healthy Adults
NCT05690945A Study of QL1706 in Combination With Chemotherapy in PD-L1-Negative Non-small Cell Lung Cancer
NCT06932107Efficacy and Safety Study of Aprepitant Injection for Prevention of Post-operative Nausea and Vomiting
NCT07178171A Study of QL1706 Combined With Short-Cycle Anthracyclines or Taxanes for the Treatment of Early-Stage TNBC
NCT05398861Utidelone Combined With Bevacizumab in the Treatment of ≥ 2 Lines of HER-2 Negative Advanced Breast Cancer
NCT06837896Efficacy and Safety Study of QLG1080 in Patients With Hormone-sensitive Advanced Prostate Cancer
NCT05932888Safety, Tolerability, and Pharmacokinetic Study of QLM3003 in Healthy Adult Subjects
NCT05345236A Study to Compare QL1207 to Eylea® in Subjects With Wet Age-related Macular Degeneration (wAMD)
NCT07062978A Comparative Study to Valuating the Efficacy and Safety of QL1206 and Prolia®
NCT03169335Efficacy and Safety of QL1101 and Avastin® Respectively Combined With Paclitaxel and Carboplatin in the First-line Treatment of Non-squamous Non-small Cell Lung Cancer
NCT02072785Phase III Study of Vincristine Sulfate Liposome For Injection In Adults With Naïve Acute Lymphoblastic Leukemia
NCT07455006Safety and Efficacy Study of QL0911 to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients
NCT07173556A Phase Ib/II Study of QLC1401 Combined With CDK4/6 or mTOR Inhibitors in ER+/HER2- Advanced Breast Cancer
NCT05799820QL1706 Monotherapy or in Combination With Bevacizumab and XELOX as First-line Treatment of Unresectable Advanced or Metastatic CRC
NCT05309629Safety and Efficacy Study of First-line Treatment With QL1706 Plus Chemotherapy in Extensive-Stage Small Cell Lung Cancer
NCT06940336To Evaluate the Efficacy and Safety of Tafamidis Meglumine Soft Capsules in the Treatment of Adult Patients With Transthyretin Amyloid Polyneuropathy
NCT05149924Efficacy and Safety of QL1012 in Women for Assisted Reproductive Treatment
NCT07345000A Study of Romiplostim N01 Plus IST vs. Placebo Plus IST for Treatment-Naive Severe Aplastic Anemia
NCT07040228A Phase Ib/II Clinical Study of Regorafenib Combined With Toripalimab and Albumin-bound Paclitaxel for the Third-line Treatment of Advanced Pancreatic Cancer
NCT04234594Comparing the Pharmacokinetic and Safety of QL1203 and Vectibix® in Healthy Males.
NCT07151872Combination of QLS31905 and Chemotherapy ± QL2107 in Patients With CLDN18.2-positive Advanced Biliary Tract Cancer
NCT07025239QL1706 Injection Plus Bevacizumab and XELOX vs Placebo Plus Bevacizumab and XELOX as First-Line Treatment of Unresectable Metastatic Colorectal Cancer
NCT07776080Iparomlimab and Tuvonralimab With Lenvatinib, Radiotherapy, and HAIC for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
NCT07256782A Study of QLC5508 Combinations in Patients With Advanced Solid Tumors
NCT05950516Efficacy and Safety of Semaglutide Ingection in Subjects With Type 2 Diabetes
NCT07400744A Study to Compare the PK , Safety, and Immunogenicity of QL2109 With Daratumumab in Male Subjects